Selective D-dimer testing strategy seems safe, effective

Selective D-dimer testing strategy seems safe, effective
For patients with suspected deep venous thrombosis (DVT), selective D-dimer testing is a safe and a more efficient testing strategy than universal testing, according to a study published in the Jan. 15 issue of the Annals of Internal Medicine.

(HealthDay)—For patients with suspected deep venous thrombosis (DVT), selective D-dimer testing is a safe and a more efficient testing strategy than universal testing, according to a study published in the Jan. 15 issue of the Annals of Internal Medicine.

Lori-Ann Linkins, M.D., from McMaster University in Hamilton, Canada, and colleagues randomized consecutive symptomatic patients with a first episode of suspected DVT to receive either selective testing (860 patients) or uniform testing (863 patients). Selective testing was defined as D-dimer testing in outpatients with low or moderate clinical pretest probability (C-PTP) (DVT excluded at D-dimer levels <1.0 µg/mL [low C-PTP] or <0.5 µg/mL [moderate C-PTP]) and venous ultrasonography without D-dimer testing in inpatients and outpatients with high C-PTP, while uniform testing was defined as D-dimer testing for all participants (with DVT excluded at D-dimer levels <0.5 µg/mL).

The researchers found that in both groups the incidence of symptomatic among patients not diagnosed with DVT during initial testing was 0.5 percent at three months. There was a 21.8 percent reduction in the proportion of patients who required D-dimer testing with the use of selective testing. With use of selective testing, the proportion of patients who required ultrasonography was reduced by 7.6 percent overall and by 21.0 percent for outpatients with low C-PTP.

"A selective D-dimer testing strategy seems as safe as and more efficient than having everyone undergo D-dimer testing when diagnosing a first episode of suspected DVT," the authors write.

Several authors disclosed to the pharmaceutical industry.

More information: Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Aspirin may prevent DVT and PE in joint replacement patients

Feb 07, 2012

Following a total joint replacement, anticoagulation (blood thinning) drugs can prevent Deep Vein Thrombosis (DVT), a blood clot deep within the extremities, or a pulmonary embolism (PE), a complication that causes a blood ...

Recommended for you

Global Ebola toll rises to 5,689: WHO

4 hours ago

The World Health Organization said Thursday that the global death toll from the Ebola virus had increased to 5,689 out of a total of 15,935 cases of infection, mainly in western Africa.

Ebola vaccine promising in first human trials

15 hours ago

Researchers say they're a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

At one month, US Ebola monitors finding no cases

17 hours ago

The U.S. program that requires weeks of monitoring for travelers from African countries with Ebola reaches the one-month mark Thursday. And so far, no cases of the disease have turned up.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.